cmAngio® vs inHEART Models
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary goal is to leverage existing mammography data for early cardiovascular risk assessment in women. This AI-powered tool efficiently identifies Breast Arterial Calcifications (BAC), offering valuable insights into a patient's cardiovascular health without requiring additional radiation or procedures. It is ideal for integrating cardiovascular risk screening into routine breast health examinations.
View cmAngio® →Choose inHEART Models if…
Choose inHEART Models if you need advanced, AI-driven 3D cardiac modeling to optimize the planning and execution of complex image-guided cardiac ablation procedures. This software creates highly detailed digital twins of the heart from CT/MR images, enabling precise pre-procedural planning and integration with electroanatomic mapping systems. It is best suited for electrophysiologists seeking to enhance procedural efficiency and improve patient outcomes for ablations.
View inHEART Models →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | inHEART Models |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact for pricing |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
inHEART ModelsTool B, inHEART Models, offers a more advanced and efficient workflow through its AI-driven automated segmentation of CT images for 3D cardiac model creation, which streamlines a complex procedure. Its seamless integration with major electroanatomic mapping systems is crucial for its specialized user base. Tool A, cmAngiou00ae, focuses on broad DICOM compatibility and quick installation, but Tool B's automation for complex tasks provides a greater leap in usability for its target users.
Clinical Value
inHEART ModelsTool B, inHEART Models, provides a direct and quantifiable impact on patient outcomes and procedural efficiency, with a potential to reduce VT procedure times by 60% and recurrence rates by 38%. While Tool A, cmAngiou00ae, offers valuable early cardiovascular risk assessment, Tool B's measurable improvements for a critical cardiac intervention demonstrate a more immediate and substantial clinical benefit.
Pricing & Value
inHEART ModelsBoth tools have opaque pricing, requiring direct vendor contact. However, Tool B, inHEART Models, quantifies significant benefits such as reducing VT procedure times by 60% and recurrence rates by 38%. These efficiencies and improved patient outcomes directly translate to substantial long-term cost savings and enhanced value for healthcare systems, providing a clearer value proposition despite undisclosed pricing.
Enterprise Readiness
cmAngio®Tool A, cmAngiou00ae, explicitly states HIPAA compliance and cybersecurity, and has demonstrated broader compatibility with multiple mammography imaging platforms (Hologic and GE Healthcare) and widespread adoption across hundreds of sites. While Tool B, inHEART Models, has FDA clearance and SOC2 compliance, Tool A's explicit claims and proven integrations give it a slight edge in demonstrated enterprise readiness.
Innovation
inHEART ModelsTool B, inHEART Models, demonstrates a higher degree of innovation with its 'digital twin of the heart' technology, offering fully automated segmentation of CT images and the ability to simulate electrical activity for complex cardiac ablations. While Tool A, cmAngiou00ae, is innovative as the first FDA-cleared AI for BAC detection, Tool B's application of AI to create interactive 3D cardiac models for pre-procedural planning is a more transformative advancement in a highly specialized field.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific details regarding the depth, scope, or quality of support services, training programs, or comprehensive documentation for either tool. Both companies provide standard contact information for support, making it difficult to differentiate between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | inHEART Models |
|---|---|---|
| Name | cmAngiou00ae | inHEART Models |
| Primary Function/Use Case | Detecting Breast Arterial Calcifications (BAC) on mammograms for cardiovascular health insights and early risk assessment. | Creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures. |
| Target Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Radiology |
| Key AI Capability | AI-based detection of Breast Arterial Calcifications (BAC) | AI-driven digital twin of the heart; automated segmentation of CT and MR images |
| Imaging Modalities Processed | Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | CT and MR images |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and inHEART Models.